HIV Stigma, HIV status disclosure, and ART adherence in the context of an integrated opioid use disorder and HIV treatment setting in Dar es Salaam, Tanzania.
HIV Stigma, HIV status disclosure, and ART adherence in the context of an integrated opioid use disorder and HIV treatment setting in Dar es Salaam, Tanzania.
复制标题
坦桑尼亚达累斯萨拉姆综合阿片类药物使用障碍和艾滋病毒治疗背景下的艾滋病毒耻辱、艾滋病毒状况披露和抗逆转录病毒治疗依从性。
DOI:
10.1080/09540121.2022.2032575
复制
发表时间:
2023
期刊:
影响因子:
1.7
通讯作者:
Nkya,IddiHaruna
中科院分区:
文献类型:
--
作者:
Saleem,HaneefaT;Knight,Deja;Yang,Cui;Kidorf,Michael;Latkin,Carl;Nkya,IddiHaruna
Little is known about social factors, including stigma, that affect antiretroviral therapy (ART) adherence among people enrolled in opioid use disorder treatment (OUDT) in the context of integrated OUDT and HIV treatment models. We qualitatively examined the relationship between HIV stigma, HIV status disclosure, and ART adherence among clients living with HIV at an OUDT clinic with integrated HIV services in Tanzania. We conducted in-depth interviews with 25 clients receiving HIV care at an OUDT clinic in Dar es Salaam, Tanzania between January and April 2020. HIV stigma, particularly anticipated stigma, and HIV status disclosure were key factors that affected ART adherence. Participants feared non-voluntary HIV status disclosure to and HIV stigma from their peers enrolled in OUDT. Most participants reported concealing their HIV status from peers at the OUDT clinic and not associating with other clients living with HIV at the clinic. Reducing HIV stigma and enhancing clinic structures and procedures to maintain privacy and confidentiality are essential to mitigating the effects of stigma on ART adherence.